Announcements

  • PCPC

SickKids node acquires Orbitrap Fusion Lumos with ETD and UVPD

Acquired by SPARC MA in August 2018 as part of Dr. Moran’s CFI-IF award, the innovative Tribrid architecture of the Orbitrap FusionTM LumosTM mass spectrometer enables unprecedented gains in biological system characterization. Equipped with ETD and UVPD fragmentation modes, it is our most selective and versatile instrument. The Lumos can analyze the most challenging, low-abundance, high-complexity samples and is also engineered to handle heavier protein fragments.

9 views

Recent Posts

See All

Our Funding Partners

genome_canada_logo.png
CFI_WHT.png
Genome_BC_logo.png

© Pan-Canadian Proteomic Centre 2020